MMWR Booster -

MMWR Booster for: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022, Weekly / December 30, 2022 / 71(5152);1625–1630

Posted on January 2, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways 1. Effectiveness of Bivalent Booster: The study found an 84% effectiveness of the bivalent booster against COVID-19 hospitalization compared to unvaccinated individuals. 2. Relative Vaccine Effectiveness: Compared

MMWR Booster for: Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults — United States, May–November 2022, December 30, 2022 / 71(5152);1605–1609

Posted on January 1, 2024 by Cody Micah Carmichael MPH, CPH

In this entry of MMWR Booster, a summary is provided about findings regarding Clinical and Epidemiological Data in regards to Mpox in Gender Diverse Persons.

MMWR Booster for: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022, Weekly / March 17, 2023 / 71(53);1637–1646

Posted on January 1, 2024 by Cody Micah Carmichael MPH, CPH

In this entry of MMWR Booster, a summary is provided about findings regarding COVID mRNA Vaccine effectiveness in preventing severe hopsitalizations and outcomes.

Epidemiology, Broadly Speaking

Category: MMWR Booster